Infectious Disease Control

NCH Taiwan Donated Disinfectants and Accompanied the Elders

TAIPEI, Jan. 19, 2022 /PRNewswire/ -- In December 2021, NCH Taiwan donated 50 pails of Everbrite Plus to Landseed International Hospital, which has been supporting and conductingCOVID-19 test in Taoyuan International Airport since the outbreak of virus. "Landseed hospital has been given great res...

2022-01-19 10:00 2095

Manulife Asia Care Survey: Hong Kong public keen to learn more about "Long COVID" as pandemic continues

* 59% of Hong Kongers say pandemic will last at least another 12 months; a fifth even say it will never end * Only a third are aware of "Long COVID" despite widespread concerns about COVID-19's impact across people from all walks of lives inHong Kong; with nine in ten wanting to better unders...

2022-01-19 09:41 4746

Bill & Melinda Gates Foundation and Wellcome Pledge US$300 Million to CEPI for COVID-19 Pandemic Response and to Accelerate Epidemic Preparedness

SEATTLE and LONDON, Jan. 19, 2022 /PRNewswire/ -- Today the Bill & Melinda Gates Foundation and Wellcome each pledgedUS$150 million for a total of US$300 million to the Coalition for Epidemic Preparedness Innovations (CEPI), a global partnership launched five years ago this week by the government...

2022-01-19 07:01 2395

CliniSys acquires HORIZON Lab Systems and combines with Sunquest Information Systems to create one of the world's largest organizations dedicated to diagnostics and laboratory informatics

·  Combined group to enable better public health outcomes through innovation in diagnostics and laboratory informatics technology TUCSON, Arizona, Jan. 18, 2022 /PRNewswire/ -- CliniSys is announcing the recent acquisition of HORIZON Lab Systems and the combination with Sunquest Information Syst...

2022-01-18 22:00 1951

Menarini Diagnostics CoronaMeltVAR Real-Time PCR kit simultaneously detects SARS CoV-2 and identifies the Omicron Variant

FLORENCE, Italy, Jan. 17, 2022 /PRNewswire/ -- The new Omicron variant is spreading rapidly causing an increase in infections at unprecedented speed. On November 28th, WHO officially recommended laboratories to use Real Time PCR detection kits capable of identifying putative Omicron variant in...

2022-01-17 22:12 2973

Seegene Continues to Support Israel's Effort to Manage the Omicron Variant With Timely Delivery of Five Million Tests

SEOUL, South Korea, Jan. 17, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, announced today that it has delivered over five million COVID-19 tests toIsrael to help detect and mitigate the spread of the Omicron variant. The company sent 1.7 mill...

2022-01-17 20:00 2503

Seegene's Allplex™ SARS CoV-2 FluA/FluB/RSV Assay approved under Health Canada's Interim Order

SEOUL, South Korea, Jan. 17, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostic company, announced it has received approval of its Allplex™ SARS CoV-2 FluA/FluB/RSV Assay under Health Canada's Interim Order onJanuary 11. Seegene's Allplex™ SARS CoV-2 Flu...

2022-01-17 20:00 2666

LumiraDx Lab Analysis Confirms its COVID-19 Antigen Test Detects the Omicron Variant

Results from ongoing testing and monitoring of COVID-19 variants shows the rapid microfluidic test detects Omicron at a comparable sensitivity to other variants LONDON, Jan. 14, 2022 /PRNewswire/ -- LumiraDx (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced tha...

2022-01-14 19:18 2938

Everest Medicines Enters into a Global Licensing Agreement to Develop and Commercialize Singapore's Experimental Drug Development Centre's 3CL Protease Inhibitors as Potentially Best-in-Class COVID-19 Oral Antiviral Treatments Worldwide

SHANGHAI, Jan. 14, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), andSingapore's Experimental Drug Development Centre ("EDDC") today announced a global licensing agreement under which Everest will obtain exclusive...

2022-01-14 08:00 4994

South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine

GAITHERSBURG, Md., Jan. 12, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and SK bioscience, Co. Limited, a vaccine business subsidiary of Korea-based SK Group, today...

2022-01-12 20:43 2175

Singapore biotech firm JN Medsys develops a PCR test kit that specifically detects for the Omicron variant with high accuracy

SINGAPORE, Jan. 12, 2022 /PRNewswire/ -- Singapore-based biotech firm, JN Medsys announces that it has developed a new PCR kit that detects for SARS-CoV-2 and identifies if the Omicron variant is present. It can be used on upper respiratory samples and the results can be available in just 1 hour....

2022-01-12 18:18 1861

BGI Genomics, Chinese gene test company, showcases high-throughput COVID testing air lab at Dubai World Expo

DUBAI, UAE, Jan. 12, 2022 /PRNewswire/ -- From January 11 to 13, a model of BGI Genomics' Huo-Yan Air Laboratory, was showcased at the China Pavilion of Dubai World Expo. With the continuing spread of COVID-19 worldwide, the Huo-Yan Air Laboratory, which can be set up anywhere in a very...

2022-01-12 17:18 2073

MGI Aims to Boost its Market Share through Participation at Expo 2020 Dubai's Guangdong Week

DUBAI, UAE, Jan. 11, 2022 /PRNewswire/ -- Global life science innovator MGI Tech Co. Ltd. (MGI) is aiming to boost its market share in theMiddle East and Asia through participation at Guangdong Week, a dedicated event taking place at the world exhibition's China Pavilion fromJanuary 11-13. The ...

2022-01-11 14:00 2024

Keep Your Home Safe and Build a Protected Community Against Omicron with Circle HealthPod

* Circle HealthPod detects >99.9% of known COVID-19 strains, including the Omicron variant, in approximately 20 minutes * With technology developed at the University of Oxford, the Circle HealthPod is a CE-IVD marked rapid detection system with 98.4% molecular accuracy * Frequent testing wit...

2022-01-11 09:00 2358

COVID-19 Oral Vaccine and Antibody Booster: B. subtilis Spores, Biotechnology Breakthrough by DreamTec

HONG KONG, Jan. 5, 2022 /PRNewswire/ -- Vaccines have been a trending topic ever since the coronavirus outbreak two years ago. DreamTec Research Limited (DreamTec,http://www.dreamtec.hk ) has its major breakthrough in developing a COVID-19 oral vaccine. In its recently pu...

2022-01-05 10:00 3675

Ascletis Expands Ritonavir Oral Tablet Production and Announces Oral Direct-Acting Antiviral Pipeline Against SARS-CoV-2 Virus

- Ritonavir oral tablet annual production capacity has been expanded to 100 million tablets and can be further rapidly expanded based on market demand - ASC10 is an oral direct-acting antiviral drug candidate targeting RNA dependent RNA polymerase (RdRp) to treat SARS-CoV-2 infection - ASC11 is ...

2022-01-03 08:30 3647

Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in India

GAITHERSBURG, Md. and PUNE, India, Dec. 29, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII), the world's largest vaccine m...

2021-12-29 03:57 3468

ChemRar Group announces the Russian Avifavir® drug is effective against variants of COVID-19, including Delta and Omicron

Avifavir® is effective against various variants of coronavirus, including Delta and Omicron, as it affects the highly conservative and mutation-resistant replication systems of RNA virus (RdRp). The virus is incapable of developing resistance to favipiravir even with long-term exposure on infect...

2021-12-27 21:20 2878

Brii Bio Doses First Patient in Phase 2a/2b Clinical Trial of BRII-179 (VBI-2601) for the Functional Cure of Chronic Hepatitis B

DURHAM, N.C. and BEIJING, Dec. 27, 2021 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public healt...

2021-12-27 18:45 3424

Documentary Zhong Nanshan/ZNS Aired on Discovery Channel in Southeast Asia

GUANGZHOU, China, Dec. 27, 2021 /PRNewswire/ -- On December 28, 2021, the single-episode character documentaryZhong Nanshan/ZNS, jointly produced by Guangdong Radio and Television and the pioneering global entertainment document provider, Discovery Inc., was broadcast on Discovery Channel inSouth...

2021-12-27 11:11 3115
1 ... 18192021222324 ... 79